Brief Description of Measure:
CMS122: Diabetes: Hemoglobin A1c (HbA1c) Poor Control (> 9%)
Percentage of patients 18-75 years of age with diabetes who had hemoglobin A1c > 9.0% during the measurement period
Description of Issue:
This update is being made in conjunction with another proposed update to add glucose management indicator (GMI) as option to meet Numerator criteria (
https://oncprojectracking.healthit.gov/support/browse/CQM-6416).
In previous versions of the measure, the intent of the measure was to monitor glycemic levels using HbA1c lab values only. With the transition to include GMI alongside HbA1c multiple glycemic assessments may occur on the same day (HbA1c or GMI), although this scenario is uncommon. To promote effective compliance with Numerator criteria, the measure developer proposes to update the measure such that providers are able to prioritize the lowest result obtained on the same day. This way, there is no implication of a preference for one type of glycemic status assessment over the other as the objective is to optimize the quality of care without favoring a particular assessment method.